Open Access
Subscription Access
Open Access
Subscription Access
Progress in the Development of Malaria Vaccine
Subscribe/Renew Journal
Malaria is caused by the unicellular, parasitic eukaryotic organism Plasmodium sp. The disease is second most cosmopolitan disease (next to tuberculosis) and produce huge economic burden to a country in terms of mortality and morbidity. In this article the progress of the development of Malaria Vaccine has been discussed.
Keywords
CSP, Duffy, Malaria, Vaccine.
User
Subscription
Login to verify subscription
Font Size
Information
- B.T. Grimberg, R. Udomsangpetch, J. Xainli, A. McHenry, T. Panichakul, J. Sattabongkot, P. A. Zimmerman. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med 2007. 4(12): e337.
- D. Nega, A. Alemu, G. Tasew. Malaria Vaccine Development: Recent Advances alongside the Barriers. J Bacteriol Parasitol 2016. 7: 300.
- I. Mueller, A.R. Shakri, C.E. Chitnis. Development of vaccines for Plasmodium vivax malaria. Vaccine 2015. 33 (52): 7489-7495.
- J. Oliveira-Ferreira, L.R. Pratt-Riccio, M. Arruda, F. Santos, C.T. Ribeiro, et al. HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria. Acta Trop 2004. 92: 63-69.
- L. H. Miller, S. J. Mason, J. A Dvorak, M. H. McGinniss, I. K. Rothman. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 1975. 189(4202): 561-563.
- M.L. Plassmeyer, K. Reiter, R.L. Jr Shimp, S. Kotova, P.D. Smith, D.E. Hurt, et al. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 2009. 284(39):26951-63.
Abstract Views: 422
PDF Views: 3